Back to Ovarian Cancer
This trial is complete. It is no longer accepting participants. Results may be available on ClinicalTrials.gov.

NCT03779399

NCT03779399
Completed Not Applicable

Who may be able to join

Who might be able to join this trial:

  • You are willing and able to give written consent to take part in the trial
  • You are between 18 and 75 years old
  • You have a tumor on your ovary

Who may not be able to join:

  • You are under 18 years old
  • Your tumor has areas of dead or dying tissue (known as necrosis)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

Trial details

Status
Completed
Phase
Not Applicable
Sponsor
Medical University of Lublin
Registry
clinicaltrials_gov
Start date
1 December 2011
Est. completion
31 May 2014

Where this trial is recruiting

🇵🇱 Poland

Primary endpoints

Percentage of Treg, Th17, NKT in peripheral blood and tissue; Value of ROMA in serum

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

View original record on ClinicalTrials.gov